Epinephrine is the only effective treatment for serious allergic reactions called anaphylaxis, yet people with prescriptions for the lifesaving medication often don t carry their auto-injectors, and many hesitate to use them.
In a phase 3 trial of adults and adolescents with hard-to-treat eosinophilic esophagitis, 6 months of weekly dupilumab sent 59% of participants into disease remission.
Despite having a PEG allergy or reacting to the first COVID-19 shot, most patients can safely complete the vaccine series, according to studies that call into question if PEG is the true culprit.